KRAS and pancreatic neoplasm: Mouse models with pancreas-specific expression of mutant K-ras from the embryonic stage frequently develop acinar-to-ductal metaplasia and pancreatic intraductal neoplasms (PanINs), but few pancreatic cancers under normal conditions [24-26].